| 注册
首页|期刊导航|临床肝胆病杂志|水飞蓟宾治疗药物性肝损伤的研究进展

水飞蓟宾治疗药物性肝损伤的研究进展

邵爽 刘春燕 高沿航

临床肝胆病杂志2017,Vol.33Issue(6):1179-1182,4.
临床肝胆病杂志2017,Vol.33Issue(6):1179-1182,4.DOI:10.3969/j.issn.1001-5256.2017.06.035

水飞蓟宾治疗药物性肝损伤的研究进展

Research advances in silybin in treatment of drug-induced liver injury

邵爽 1刘春燕 1高沿航1

作者信息

  • 1. 吉林大学第一医院肝病科,长春130021
  • 折叠

摘要

Abstract

Drug-induced liver injury is commonly seen in ctinical practice and is usually caused by antipsychotic drags,antitubercnlar agents,paracetamol,and statins.Silybin,a substance with biological activity in silymarin extract,has antioxidant,anti-inflammatory,and anti-fibrosis effects.This article summarizes the research advances in silybin in the prevention and treatment of drug-induced liver injury.

关键词

药物性肝损伤/水飞蓟素/综述

Key words

drug induced liver injury/silymarin/review

分类

医药卫生

引用本文复制引用

邵爽,刘春燕,高沿航..水飞蓟宾治疗药物性肝损伤的研究进展[J].临床肝胆病杂志,2017,33(6):1179-1182,4.

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量4
|
下载量0
段落导航相关论文